Distinct angiogenesis roles and surface markers of early and late endothelial progenitor cells revealed by functional group analyses

BMC Genomics

Volumn 14, Issue 1, 2013, Pages

  Cheng, Cheng Chung ^a   Chang, Shing Jyh ^d   Chueh, Yu Neng ^b   Huang, Tse Shun ^b   Huang, Po Hsun ^b,c   Cheng, Shu Meng ^a   Tsai, Tsung Neng ^a   Chen, Jaw Wen ^b,c   Wang, Hsei Wei ^b,e  

^a TRI SERVICE GENERAL HOSPITAL   (Taiwan)

^b NATIONAL YANG MING UNIVERSITY   (Taiwan)

^c TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

^d MACKAY MEMORIAL HOSPITAL   (Taiwan)

^e TAIPEI CITY HOSPITAL   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOGENIC FACTOR; CD133 ANTIGEN; CD34 ANTIGEN; CD45 ANTIGEN; CYTOKINE; INTERFERON REGULATORY FACTOR 6; TRANSCRIPTION FACTOR GATA 6; TRANSCRIPTION FACTOR MAF; TRANSCRIPTION FACTOR MAFB;

ANGIOGENESIS; ARTICLE; CONTROLLED STUDY; ENDOTHELIAL PROGENITOR CELL; GENE EXPRESSION; HEMANGIOBLAST; HUMAN; HUMAN CELL; MICROARRAY ANALYSIS; PARACRINE SIGNALING;

CELL PROLIFERATION; CELLS, CULTURED; CYTOKINES; ENDOTHELIAL CELLS; FEMALE; FETAL BLOOD; HUMANS; NEOVASCULARIZATION, PATHOLOGIC; NEOVASCULARIZATION, PHYSIOLOGIC; PREGNANCY; RNA, MESSENGER; STEM CELLS; TRANSCRIPTION FACTORS; TRANSCRIPTOME;

EID: 84874934679     PISSN: None     EISSN: 14712164     Source Type: Journal    
DOI: 10.1186/1471-2164-14-182     Document Type: Article

References (27)

1. Real C, Caiado F, Dias S. Endothelial progenitors in vascular repair and angiogenesis: how many are needed and what to do?. Cardiovasc Hematol Disord Drug Targets 2008, 8(3):185-193. 10.2174/187152908785849071, 18781931.
2. Asahara T, Murohara T, Sullivan A, Silver M, van der Zee R, Li T, Witzenbichler B, Schatteman G, Isner JM. Isolation of putative progenitor endothelial cells for angiogenesis. Science 1997, 275(5302):964-967. 10.1126/science.275.5302.964, 9020076.
3. Sieveking DP, Buckle A, Celermajer DS, Ng MK. Strikingly different angiogenic properties of endothelial progenitor cell subpopulations: insights from a novel human angiogenesis assay. J Am Coll Cardiol 2008, 51(6):660-668. 10.1016/j.jacc.2007.09.059, 18261686.
4. Yoon CH, Hur J, Park KW, Kim JH, Lee CS, Oh IY, Kim TY, Cho HJ, Kang HJ, Chae IH. Synergistic neovascularization by mixed transplantation of early endothelial progenitor cells and late outgrowth endothelial cells: the role of angiogenic cytokines and matrix metalloproteinases. Circulation 2005, 112(11):1618-1627. 10.1161/CIRCULATIONAHA.104.503433, 16145003.
5. Mukai N, Akahori T, Komaki M, Li Q, Kanayasu-Toyoda T, Ishii-Watabe A, Kobayashi A, Yamaguchi T, Abe M, Amagasa T. A comparison of the tube forming potentials of early and late endothelial progenitor cells. Exp Cell Res 2008, 314(3):430-440. 10.1016/j.yexcr.2007.11.016, 18083163.
6. Igreja C, Fragoso R, Caiado F, Clode N, Henriques A, Camargo L, Reis EM, Dias S. Detailed molecular characterization of cord blood-derived endothelial progenitors. Exp Hematol 2008, 36(2):193-203.
7. Caiado F, Real C, Carvalho T, Dias S. Notch pathway modulation on bone marrow-derived vascular precursor cells regulates their angiogenic and wound healing potential. PLoS One 2008, 3(11):e3752. 10.1371/journal.pone.0003752, 2582964, 19015735.
8. Medina RJ, O'Neill CL, Sweeney M, Guduric-Fuchs J, Gardiner TA, Simpson DA, Stitt AW. Molecular analysis of endothelial progenitor cell (EPC) subtypes reveals two distinct cell populations with different identities. BMC Med Genomics 2010, 3(1):18. 10.1186/1755-8794-3-18, 2881111, 20465783.
9. Huang PH, Chen YH, Chen YL, Wu TC, Chen JW, Lin SJ. Vascular endothelial function and circulating endothelial progenitor cells in patients with cardiac syndrome X. Heart 2007, 93(9):1064-1070. 10.1136/hrt.2006.107763, 1954999, 17488770.
10. Chen YH, Lin SJ, Lin FY, Wu TC, Tsao CR, Huang PH, Liu PL, Chen YL, Chen JW. High glucose impairs early and late endothelial progenitor cells by modifying nitric oxide-related but not oxidative stress-mediated mechanisms. Diabetes 2007, 56(6):1559-1568. 10.2337/db06-1103, 17389326.
11. Huang TS, Hsieh JY, Wu YH, Jen CH, Tsuang YH, Chiou SH, Partanen J, Anderson H, Jaatinen T, Yu YH. Functional network reconstruction reveals somatic stemness genetic maps and dedifferentiation-like transcriptome reprogramming induced by GATA2. Stem Cells 2008, 26(5):1186-1201. 10.1634/stemcells.2007-0821, 18308945.
12. Maeng YS, Choi HJ, Kwon JY, Park YW, Choi KS, Min JK, Kim YH, Suh PG, Kang KS, Won MH. Endothelial progenitor cell homing: prominent role of the IGF2-IGF2R-PLCbeta2 axis. Blood 2009, 113(1):233-243. 10.1182/blood-2008-06-162891, 18832656.
13. Chang YC, Chen TC, Lee CT, Yang CY, Wang HW, Wang CC, Hsieh SL. Epigenetic control of MHC class II expression in tumor-associated macrophages by decoy receptor 3. Blood 2008, 111(10):5054-5063. 10.1182/blood-2007-12-130609, 18349319.
14. Wang HW, Trotter MW, Lagos D, Bourboulia D, Henderson S, Makinen T, Elliman S, Flanagan AM, Alitalo K, Boshoff C. Kaposi sarcoma herpesvirus-induced cellular reprogramming contributes to the lymphatic endothelial gene expression in Kaposi sarcoma. Nat Genet 2004, 36(7):687-693. 10.1038/ng1384, 15220918.
15. Smyth GK. Linear models and empirical bayes methods for assessing differential expression in microarray experiments. Stat Appl Genet Mol Biol 2004, 3(1). Article3.
16. Storey JD, Tibshirani R. Statistical significance for genomewide studies. Proc Natl Acad Sci USA 2003, 100(16):9440-9445. Epub 2003 Jul 9425, 10.1073/pnas.1530509100, 170937, 12883005.
17. Yang TP, Chang TY, Lin CH, Hsu MT, Wang HW. ArrayFusion: a web application for multi-dimensional analysis of CGH, SNP and microarray data. Bioinformatics 2006, 22(21):2697-2698. 10.1093/bioinformatics/btl457, 16935928.
18. Rehman J, Li J, Orschell CM, March KL. Peripheral blood " endothelial progenitor cells" are derived from monocyte/macrophages and secrete angiogenic growth factors. Circulation 2003, 107(8):1164-1169. 10.1161/01.CIR.0000058702.69484.A0, 12615796.
19. Yang Z, von Ballmoos MW, Faessler D, Voelzmann J, Ortmann J, Diehm N, Kalka-Moll W, Baumgartner I, Di Santo S, Kalka C. Paracrine factors secreted by endothelial progenitor cells prevent oxidative stress-induced apoptosis of mature endothelial cells. Atherosclerosis 2010, 211(1):103-109. 10.1016/j.atherosclerosis.2010.02.022, 20227693.
20. Vasa M, Fichtlscherer S, Aicher A, Adler K, Urbich C, Martin H, Zeiher AM, Dimmeler S. Number and migratory activity of circulating endothelial progenitor cells inversely correlate with risk factors for coronary artery disease. Circ Res 2001, 89(1):E1-7. 10.1161/hh1301.093953, 11440984.
21. Briguori C, Testa U, Riccioni R, Colombo A, Petrucci E, Condorelli G, Mariani G, D'Andrea D, De Micco F, Rivera NV. Correlations between progression of coronary artery disease and circulating endothelial progenitor cells. FASEB J 2010, 24(6):1981-1988. 10.1096/fj.09-138198, 20056714.
22. Hagensen MK, Vanhoutte PM, Bentzon JF. Arterial endothelial cells: still the craftsmen of regenerated endothelium. Cardiovasc Res 2012, 95(3):281-289. 10.1093/cvr/cvs182, 22652005.
23. Timmermans F, Plum J, Yoder MC, Ingram DA, Vandekerckhove B, Case J. Endothelial progenitor cells: identity defined?. J Cell Mol Med 2009, 13(1):87-102.
24. Case J, Mead LE, Bessler WK, Prater D, White HA, Saadatzadeh MR, Bhavsar JR, Yoder MC, Haneline LS, Ingram DA. Human CD34 + AC133 + VEGFR-2+ cells are not endothelial progenitor cells but distinct, primitive hematopoietic progenitors. Exp Hematol 2007, 35(7):1109-1118. 10.1016/j.exphem.2007.04.002, 17588480.
25. Ryschich E, Lizdenis P, Ittrich C, Benner A, Stahl S, Hamann A, Schmidt J, Knolle P, Arnold B, Hammerling GJ. Molecular fingerprinting and autocrine growth regulation of endothelial cells in a murine model of hepatocellular carcinoma. Cancer Res 2006, 66(1):198-211. 10.1158/0008-5472.CAN-05-1636, 16397233.
26. Nowak DG, Woolard J, Amin EM, Konopatskaya O, Saleem MA, Churchill AJ, Ladomery MR, Harper SJ, Bates DO. Expression of pro- and anti-angiogenic isoforms of VEGF is differentially regulated by splicing and growth factors. J Cell Sci 2008, 121(Pt 20):3487-3495. 2613349, 18843117.
27. De Sutter J, Struyf S, Van de Veire NR, Philippe J, De Buyzere M, Van Damme J. Cardiovascular determinants and prognostic significance of CC Chemokine Ligand-18 (CCL18/PARC) in patients with stable coronary artery disease. J Mol Cell Cardiol 2010, 49(5):894-896. 10.1016/j.yjmcc.2010.07.013, 20674579.